Cargando…
Predictors of treatment resistant schizophrenia: a systematic review of prospective observational studies
Treatment-resistant schizophrenia, affecting approximately 20–30% of patients with schizophrenia, has a high burden both for patients and healthcare services. There is a need to identify treatment resistance earlier in the course of the illness, in order that effective treatment, such as clozapine,...
Autores principales: | Smart, S. E., Kępińska, A. P., Murray, R. M., MacCabe, J. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856410/ https://www.ncbi.nlm.nih.gov/pubmed/31462334 http://dx.doi.org/10.1017/S0033291719002083 |
Ejemplares similares
-
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
por: Gillespie, Amy L., et al.
Publicado: (2017) -
Schizophrenia polygenic risk predicts general cognitive deficit but not cognitive decline in healthy older adults
por: Kępińska, Adrianna P., et al.
Publicado: (2020) -
M212. A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL VARIABLES ASSOCIATED WITH RESPONSE TO CLOZAPINE IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Griffiths, Kira, et al.
Publicado: (2020) -
S62. COGNITIVE DEFICITS IN TREATMENT RESISTANT SCHIZOPHRENIA
por: Millgate, Edward, et al.
Publicado: (2020) -
41. RECONSIDERING THE EVIDENCE FOR CLOZAPINE FOR TREATMENT REFRACTORY SCHIZOPHRENIA
por: MacCabe, James
Publicado: (2018)